137 results
Page 3 of 7
8-K
EX-99.1
augy9
13 Aug 21
Chemomab Therapeutics Announces Second Quarter 2021 Financial Results and Provides a
8:03am
8-K
ntd14ccyufx0p0ap
22 Jul 21
Submission of Matters to a Vote of Security Holders
8:30am
8-K
EX-99.1
x7jvmk6
13 May 21
Chemomab Therapeutics Announces First Quarter 2021 Financial Results and Provides a Business Update
9:30am
8-K/A
ssu4ilsdq 4sv75iq
14 Apr 21
UNAUDITED PRO FORMA Condensed COMBINED FINANCIAL STATEMENTS
11:50am
8-K/A
EX-99.1
muzuqfa461j0c2v
14 Apr 21
UNAUDITED PRO FORMA Condensed COMBINED FINANCIAL STATEMENTS
11:50am
D
ly5o8ut6buc5afrk0
30 Mar 21
$45.45M in equity / options / securities to be acquired, sold $45.45M, 26 investors
7:48am
8-K
EX-99.2
lj4170nif1xhfmr3197
17 Mar 21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
12:00am
8-K
EX-3.1
6752h
17 Mar 21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
12:00am
8-K
EX-10.1
mumq3zhikw4 xjhd
17 Mar 21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
12:00am
8-K
op33 bczl
10 Mar 21
Other Events
12:00am
425
6ql3xevu51y 4x1mmhy1
10 Mar 21
Business combination disclosure
12:00am
425
ml6zajuucfb1
9 Mar 21
Business combination disclosure
1:00pm
424B3
u1kyus43jg7ddw4
12 Feb 21
Prospectus supplement
12:05pm